Northern Epilepsy: A Novel Form of Neuronal Ceroid‐Lipofuscinosis
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Northern epilepsy is an autosomal recessive childhood onset epilepsy syndrome, clinically characterized by generalized tonic‐clonic seizures with onset at 5 to 10 years of age and subsequent slowly progressive mental deterioration. The patients may reach 50 or 60 years of age. A mutation responsible for the disease has recently been identified in a novel gene on chromosome 8p23, encoding a putative membrane protein with an unknown function. The present study, based on three autopsied patients, is the first neuropathological analysis of the disease, and showed intraneuronal accumulation of cytoplasmic autofluorescent granules. The granules were strongly stained by the Luxol fast blue, periodic acid‐Schiff, and Sudan black B methods in paraffin sections, and were immunoreactive for subunit c of the mitochondrial ATP synthase and sphingolipid activator proteins A and D. The intraneuronal storage was highly selective: the third layer of the isocortex and the hippocampal CA2, CA3, and CA4 sectors were severely affected, while other layers of the isocortex, the CA1 sector, and the cerebellar cortex were only minimally involved. The membrane‐bound storage cytosomes showed a curvilinear ultrastructure with admixture of some granular components. Western blotting and N‐terminal sequence analysis of purified storage material identified subunit c as the major component. These findings establish Northern epilepsy as a new form of neuronal ceroid‐lipofuscinosis with an exceptionally protracted course.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Northern epilepsy syndrome: clinical course and the effect of medication on seizures
Hirvasniemi, A., Herrala, P., & Leisti, J. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01616.x · Cited by 39
Self-citation
Cited by
The Neuronal Ceroid-Lipofuscinoses
Haltia, M. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.1 · Cited by 353
Self-citationKousi, M., Lehesjoki, A.-E., & Mole, S. E. (2012) · Human Mutation · doi:10.1002/humu.21624 · Cited by 332
Mole, S. E., Williams, R. E., & Goebel, H. H. (2005) · Neurogenetics · doi:10.1007/s10048-005-0218-3 · Cited by 307
NCL diseases - clinical perspectives
Schulz, A., Kohlschütter, A., Mink, J., Simonati, A., & Williams, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.008 · Cited by 246
Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs)
Holopainen, J. M., Saarikoski, J., Kinnunen, P. K. J., & Järvelä, I. (2001) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02530.x · Cited by 211
Metadata
- Authors
- Herva, R., Tyynelä, J., Hirvasniemi, A., Syrjäkallio‐Ylitalo, M., & Haltia, M.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2000-04
- Volume
- 10
- Issue
- 2
- Pages
- 215-222
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- OpenAlex
- W2073924233
- Cited by
- 95
- References
- 1
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Northern Epilepsy: A Novel Form of Neuronal Ceroid‐Lipofuscinosis. https://app.cochat.ai/papers/10.1111/j.1750-3639.2000.tb00255.x
- The paper
- Herva, R., Tyynelä, J., Hirvasniemi, A., Syrjäkallio‐Ylitalo, M., & Haltia, M. (2000). Northern Epilepsy: A Novel Form of Neuronal Ceroid‐Lipofuscinosis. Brain Pathology. https://doi.org/10.1111/j.1750-3639.2000.tb00255.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.